Pharmaceutical Technology, Apr 1, 2011 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
Pharmaceutical Technology, Apr 1, 2011
Special Feature
Audio: Excipient Functionality and Continuous Manufacturing
Listen to roundtables from the 2011 ExcipientFest/IPEC conference, addressing developing issues in excipient functionality and continuous manufacturing.
Featured Content
Exploring Excipient Functionality
By Patricia Van Arnum
This technical forum is part of a special issue on Solid Dosage and Excipients.
Innovations in Tablet Coating
Representatives from Pfizer R&D, DEM Solutions, Colorcon, and ARmark Authentication Technologies provide insight into recent tablet-coating technologies.
Oral-Absorption-Enhancing Drug-Delivery Technology
By Edwin G. Walsh , John S. Fox , Thomas W. Leonard
The authors examine an oral-absorption-enhancement technology based on surface-active materials to increase apical membrane fluidity in vitro.
Correlating Die-Filling Performance with Powder Properties
By Tim Freeman
The author explains how to gain an understanding of the relationships between powder characteristics and process performance to match filling-machine geometry to the demands of specific formulations.
Risk Assessment for Excipients for Enhanced Patient Safety
By Dale Carter
The author describes key considertions for a complete risk-assessment model and provides insight into a pending IPEC guideline in this area.
Total Excipient Control: A Pathway to Increased Patient Safety
By David R. Schoneker
The author focuses on how industry can build a system for Total Excipient Control.
Exploring Nanotechnology in Drug Delivery
By Patricia Van Arnum
Nanotechnology often is associated with parenteral drug delivery, particularly for anticancer therapies, but it also has applications in oral drug delivery

ADVERTISEMENT
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
21%
To all process for new products only
13%
To select process for new products only
26%
To select processes for both new and legacy products
21%
Do not use QbD
21%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Featured Jobs

More Jobs
Click here